LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    EuropaBio Members nominate Europe’s biotechnology landmarks from the last 25 years

    03/07/2021
    PRESS RELEASE

    Brussels, 5 July 2021

    From micro-organism production of the world’s vitamin B2, a revolution in cancer therapy using our own immune systems, and the first Covid mRNA vaccine approved – these are just a few examples of the selected landmarks in biotechnology that were officially announced today as the start of EuropaBio’s 25th Anniversary programme.

    To mark a quarter century of impactful biotechnology since EuropaBio launch, members have been nominating important scientific, industry and ecosystem developments that shape our lives now. Today sees publication of almost 30 nominations in the first wave received from Members, with over 50 anticipated by the end of anniversary celebrations in 2021. They recognise brilliant science, innovative companies beakthroughs and a European landscape that enabled new medicines and novel materials.

    ‘I am thrilled that we received so many excellent nominations from Members, and these show us that biotechnology impacts so many aspects of our lives.. Behind every headline product, are decades of scientific advance from researchers and innovators in the public and private sector. They are, in turn, enabled by the collaborative landscape that Europe has built across borders to amplify strengths and grow together. Our 25th anniversary is a great opportunity not only to celebrate these achievements but also to gather the community and look ahead to the next 25 years.’, says Dr Claire Skentelbery, Director General of EuropaBio.

    The anniversary nominations will be amplified through webinars, interviews, conversations on social media discussing some of the key drivers that made them a reality. The year will end with a gala evening in Brussels recognising the best healthcare and industrial biotechnology advances from the anniversary. The ceremony will be followed by a presentation of the 2021 SME Award from EuropaBio, looking to the next generation of landmark biotechnology innovation.

    Visit the dedicated anniversary website at www.europabio25.org and follow EuropaBio anniversary celebrations through our weekly newsletter.

    EuropaBio Members nominate Europe’s biotechnology landmarks from the last 25 years


    Download
    Share
    Communications Team
    Communications Team

    Related posts

    29/05/2026

    The Luxembourg Institute of Science and Technology joins EuropaBio: Advancing Applied Biotechnology in Europe


    Read more
    26/05/2026

    EuropaBio Position on the Food and Feed SafetyOmnibus (May 2026)


    Read more
    18/05/2026

    Biodefence & Biosecurity in focus for EuropaBio with dedicated Task Force


    Read more

    Important links

    • The Luxembourg Institute of Science and Technology joins EuropaBio: Advancing Applied Biotechnology in Europe
    • EuropaBio Position on the Food and Feed SafetyOmnibus (May 2026)

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.